Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Konstantin Shelepen"'
Autor:
Siarhei Panko, Aleksandr Karpitski, Konstantin Shelepen, Mikalaj Kazarez, Denis Vakulich, Rostislaw Boufalik, Andrej Shestiuk, Genadz Zhurbenka, Alaksandr Ignatiuk
Publikováno v:
Studia Medyczne, Vol 29, Iss 3, Pp 203-212 (2013)
Introduction: Lung cancer has been the most common cancer in the world and in Belarus. Aim of the research: To evaluate the epidemiology of non-small cell lung cancer and improvements in diagnostics and treatment for the past 11 years in the Brest Re
Externí odkaz:
https://doaj.org/article/7799fa500c7147a393fd160a59e8f361
Autor:
Daniil Stroyakovskiy, Natalya Fadeeva, Marina Matrosova, Konstantin Shelepen, Grigoriy Adamchuk, Bodhisatta Roy, Rajnish Nagarkar, Mahesh Kalloli, Daria Zhuravleva, Georgiy Voevodin, Mariya Shustova, Fedor Kryukov
Background BCD-021 is a bevacizumab biosimilar which was shown to be equivalent to reference bevacizumab in a wide panel of physicochemical studies as well as preclinical studies in vitro and in vivo. International multicenter phase III clinical tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c576b5cd120f7be5c0b189e608f80722
https://doi.org/10.21203/rs.3.rs-763106/v1
https://doi.org/10.21203/rs.3.rs-763106/v1
Autor:
Genadz Zhurbenka, Konstantin Shelepen, Rostislaw Boufalik, Aleksandr Karpitski, Andrej Shestiuk, Denis Vakulich, Mikalaj Kazarez, Siarhei Panko, Alaksandr Ignatiuk
Publikováno v:
Studia Medyczne, Vol 29, Iss 3, Pp 203-212 (2013)
Introduction: Lung cancer has been the most common cancer in the world and in Belarus. Aim of the research: To evaluate the epidemiology of non-small cell lung cancer and improvements in diagnostics and treatment for the past 11 years in the Brest Re